Business Context and Reporting Period
Company: Advanced Micro Devices, Inc. (AMD)
Filing Type: Form 8-K (Current Report)
Date of Report: October 27, 2005
Event: Entry into a Material Definitive Agreement (Second Amended and Restated "S" Process Development Agreement with IBM).
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, debt, or liquidity metrics. It focuses on contractual obligations.
- Estimated Development Costs (2005–2011): AMD expects to pay IBM between $518 million and $578 million for its share of joint development costs from September 25, 2005, through the fiscal quarter ending December 25, 2011.
- Payment Terms: Fees are generally payable on a quarterly basis.
- Variable Costs: Actual amounts depend on the number of partners engaged in related development projects.
- Royalties: AMD agreed to pay specified royalties upon certain events, such as sublicensing jointly developed technologies or bumping wafers for third parties.
Material Changes and Agreement Details
The Board of Directors approved an amendment to the "S" Process Development Agreement with IBM, originally executed in September 2004. Key changes include:
- Term Extension: The joint development relationship is extended for three years, from December 31, 2008, to December 31, 2011.
- Scope of Development: Continued joint development of 32-nanometer, 22-nanometer, and other advanced technologies on silicon wafers, plus laboratory-based research.
- Licensing Rights:
- Extension of licenses for 32-nanometer and more advanced technologies.
- Additional licenses to manufacture wafers for third parties.
- Right to sublicense jointly developed process technology to third-party foundries or joint manufacturing facilities.
- Licensing of bump technology if jointly developed during the term.
Outlook, Risks, and Contingencies
Conditions Precedent: Continuation of capital purchases by IBM for projects past December 31, 2008, is conditioned upon approval by IBM's Board of Directors.
Termination Rights:
- If IBM's Board does not approve the agreement by September 30, 2007, either party may terminate the agreement effective December 31, 2008, without liability.
- Immediate termination is permitted if a party permanently ceases business, becomes bankrupt/insolvent, liquidates, or undergoes a change of control.
- Either party may terminate upon 30 days' written notice for failure to perform a material obligation.
Related Agreements: AMD and IBM maintain a patent cross-license agreement covering applications filed prior to July 1, 2005, along with other license and consulting services agreements.
Investor Verification Checklist
- Verify the final number of partners in the development projects to determine the exact cost share within the $518 million to $578 million range.
- Monitor IBM's Board of Directors' decision deadline (September 30, 2007) regarding capital purchases for the post-2008 term.
- Review future filings for details on royalty payments triggered by sublicensing or third-party wafer bumping.
- Confirm the status of the patent cross-license agreement and any potential disputes regarding pre-July 2005 applications.